HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 258 filers reported holding HAEMONETICS CORP in Q4 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,289,952 | +12.2% | 14,400 | +6.7% | 0.01% | +7.7% |
| Q2 2023 | $1,149,390 | +20.8% | 13,500 | +17.4% | 0.01% | +18.2% |
| Q1 2023 | $951,625 | +146.9% | 11,500 | +134.7% | 0.01% | +175.0% |
| Q4 2022 | $385,385 | +68.3% | 4,900 | +58.1% | 0.00% | +100.0% |
| Q3 2022 | $229,000 | -82.5% | 3,100 | -83.2% | 0.00% | -81.8% |
| Q3 2021 | $1,305,000 | -39.6% | 18,497 | -43.0% | 0.01% | -31.2% |
| Q2 2021 | $2,160,000 | – | 32,434 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
| Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
| HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
| Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
| Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
| Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
| ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
| CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
| Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |